<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03469037</url>
  </required_header>
  <id_info>
    <org_study_id>2018-A00178- 47</org_study_id>
    <nct_id>NCT03469037</nct_id>
  </id_info>
  <brief_title>Effects on Experimental Dyspnea of High Flow Nasal Cannula</brief_title>
  <acronym>EDEN</acronym>
  <official_title>Effects on an Experimental Dyspnea by Thoraco-abdominal Elastic Strapping of the High Flow Nasal Cannula</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Association pour le Développement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Association pour le Développement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To develop an experimental model of dyspnea by external thoraco-abdominal elastic strapping
      at rest in order to study the mechanisms involved in the relief of dyspnea by the
      administration of high flow by nasal cannula (HFNC).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will measure the effect of HFNC on an experimental model of dyspnea induced by
      thoraco-abdominal elastic strapping on healthy subjects at rest.

      The study will also compare the effects on dyspnea of the administration of high flow nasal
      cannula with and without oxygen added.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 10, 2018</start_date>
  <completion_date type="Anticipated">November 30, 2018</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effects of high flow nasal cannula on strapping induced type of dyspnea</measure>
    <time_frame>One hour</time_frame>
    <description>Evaluated by visual annylogic scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Compare the effect of the high flow by nasal cannula with and without oxygen on an experimental dyspnea, evaluated by the differences of changes in the visual analogic scale</measure>
    <time_frame>One hour</time_frame>
    <description>Evaluated by visual annylogic scale</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">32</enrollment>
  <condition>Dyspnea</condition>
  <condition>Healthy Volunteers</condition>
  <arm_group>
    <arm_group_label>Oxygen first</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Optiflow with an inspired fraction of oxygen of 100% in the first seance Optiflow with an inspired fraction of oxygen of 21 % in the second seance</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Air first</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Optiflow with an inspired fraction of oxygen of 21 % in the first seance Optiflow with an inspired fraction of oxygen of 100 % in the second seance</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Optiflow with an inspired fraction of oxygen of 100%</intervention_name>
    <description>Respiratory gaz heated and humidified system of delivery with a fraction of oxygen inspired of 100%</description>
    <arm_group_label>Oxygen first</arm_group_label>
    <arm_group_label>Air first</arm_group_label>
    <other_name>High flow nasal cannula with oxygen added</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Optiflow with an inspired fraction of oxygen of 21%</intervention_name>
    <description>Respiratory gaz heated and humidified system of delivery with a fraction of oxygen inspired of 21%</description>
    <arm_group_label>Oxygen first</arm_group_label>
    <arm_group_label>Air first</arm_group_label>
    <other_name>High flow nasal cannula without oxygen added</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy volunteers

        Exclusion Criteria:

          -  chronic pathology

          -  active smokers

          -  anxiety disorder

          -  allergy to latex

          -  protected adult

          -  woman declared herself pregnant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Capucine Morelot-Panzini, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Service de Pneumologie de la Pitié-Salpétrière</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thomas Similowski, PHD</last_name>
    <role>Study Director</role>
    <affiliation>Service de Pneumologie de la Pitié-Salpétrière</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Clara Bianquis, Intern</last_name>
    <phone>+33648206670</phone>
    <email>clarabqs@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Camille Rolland-Debord, Doctor</last_name>
    <phone>+33622288801</phone>
    <email>camille.rolland-debord@aphp.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Laboratoire de Physiopathologie Respiratoire du Service de Pneumologie et de Réanimation</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Thomas Similowski, Professor</last_name>
    </contact>
    <investigator>
      <last_name>Capucine Morelot-Panzini, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thomas Similowski, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Camille Rolland-Debord, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Clara Bianquis, Intern</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service de Pneumologie et Réanimation Médicale</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 25, 2018</study_first_submitted>
  <study_first_submitted_qc>March 12, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 19, 2018</study_first_posted>
  <last_update_submitted>May 15, 2018</last_update_submitted>
  <last_update_submitted_qc>May 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Dyspnea, High flow nasal cannula</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dyspnea</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

